Measurement of lung clearance index (LCI <sub>2.5</sub> ) by nitrogen multiple breath washout (N <sub>2</sub> -MBW) is feasible and well-tolerated by adults and children with cystic fibrosis
BACKGROUND: -MBW in adults and children/adolescents with CF within the exercise as an airway clearance technique-CF feasibility trial. METHODS: 70% vs <70% predicted). Participants also completed a questionnaire assessing acceptability and willingness to repeat testing. RESULTS: -MBW testing. CONCLUSIONS: represents a robust outcome measure for consideration in CF clinical trials. TRIAL REGISTRATION NUMBER: NCT05482048.
Authors
- Zoe L. Saynor (ORCID: https://orcid.org/0000-0003-0674-8477)
- S. Cunningham
- Mary Abkir
- E. L. Taylor
- Donna Bowens
- Debbie Miller
- Don S Urquhart
- Clare J Saunders
- Ellen Lacey
Institutions
- Western General Hospital (GB)
- Cystic Fibrosis Trust (GB)
- Royal Hospital for Children (GB)
- University Hospital Southampton NHS Foundation Trust (GB)
- Centre for Inflammation Research (GB)
- University of Southampton (GB)
- Imperial College London (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- BMJ Open Respiratory Research
- Published
- 2026-04-01
- DOI
- https://doi.org/10.1136/bmjresp-2025-003905
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Portsmouth
- Northumbria University
- University Hospital Southampton NHS Foundation Trust
- National Institute for Health and Care Research
- Department of Health and Social Care
- Cystic Fibrosis Trust
- Imperial College London